Self-reported and laboratory evaluation of late pregnancy nicotine exposure and drugs of abuse

Journal of Perinatology

Volumn 36, Issue 10, 2016, Pages 814-818

  Hall, E S ^a,b   Wexelblatt, S L ^a   Greenberg, J M ^a,b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b Cradle Cincinnati   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; BUPRENORPHINE; CANNABINOID; COCAINE; COTININE; DIAMORPHINE; METHADONE; MUSCLE RELAXANT AGENT; NICOTINE; OPIATE; PHENCYCLIDINE; BIOLOGICAL MARKER; NARCOTIC ANALGESIC AGENT; STREET DRUG;

ADULT; ARTICLE; BIRTH CERTIFICATE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG ABUSE; DRUG DETERMINATION; DRUG EXPOSURE; DRUG SCREENING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; MATERNAL EXPOSURE; MEDICAID; PASSIVE SMOKING; POLYPHARMACY; PREVALENCE; RACE DIFFERENCE; RETROSPECTIVE STUDY; RISK FACTOR; SELF REPORT; SMOKING CESSATION; THIRD TRIMESTER PREGNANCY; VITAL STATISTICS; BLOOD; CHI SQUARE DISTRIBUTION; EPIDEMIOLOGY; PREGNANCY; SMOKING; STATISTICS AND NUMERICAL DATA; SUBSTANCE ABUSE; URINE;

ANALGESICS, OPIOID; BIOMARKERS; CHI-SQUARE DISTRIBUTION; COTININE; FEMALE; HUMANS; MATERNAL EXPOSURE; NICOTINE; PREGNANCY; PREGNANCY TRIMESTER, THIRD; RETROSPECTIVE STUDIES; SELF REPORT; SMOKING; STREET DRUGS; SUBSTANCE ABUSE DETECTION; TOBACCO SMOKE POLLUTION;

EID: 84978173022     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2016.100     Document Type: Article

References (38)

1. Aliyu MH, Lynch O, Saidu R, Alio AP, Marty PJ, Salihu HM. Intrauterine exposure to tobacco and risk of medically indicated and spontaneous preterm birth. Am J Perinatol 2010; 27(5) 405-410.
2. Ko TJ, Tsai LY, Chu LC, Yeh SJ, Leung C, Chen CY, et al. Parental smoking during pregnancy and its association with low birth weight, small for gestational age, and preterm birth offspring: a birth cohort study. Pediatri Neonatol 2014; 55(1): 20-27.
3. Salihu HM, Aliyu MH, Pierre-Louis BJ, Alexander GR. Levels of excess infant deaths attributable to maternal smoking during pregnancy in the United States. Matern Child Health J 2003; 7(4): 219-227.
4. Isayama T, Shah PS, Ye XY, Dunn M, Da Silva O, Alvaro R, et al. Adverse impact of maternal cigarette smoking on preterm infants: a population-based cohort study. Am J Perinatol 2015; 32(12): 1105-1111.
5. Markowitz S. The effectiveness of cigarette regulations in reducing cases of Sudden Infant Death Syndrome. J Health Econ 2008; 27(1): 106-133.
6. Mohsin M, Jalaludin B. Influence of previous pregnancy outcomes and continued smoking on subsequent pregnancy outcomes: an exploratory study in Australia. BJOG 2008; 115(11): 1428-1435.
7. Castro LC, Azen C, Hobel CJ, Platt LD. Maternal tobacco use and substance-Abuse -reported prevalence rates and associations with the delivery of small-forgestational-Age neonates. Obstet Gynecol 1993; 81(3): 396-401.
8. McFarlane J, Parker B, Soeken K. Physical abuse, smoking, and substance use during pregnancy: prevalence, interrelationships, and effects on birth weight. J Obstet Gynecol Neonatal Nurs 1996; 25(4): 313-320.
9. Tong VT, Dietz PM, Morrow B, D'Angelo DV, Farr SL, Rockhill KM, et al. Trends in smoking before, during, and after pregnancy-Pregnancy Risk Assessment Monitoring System, United States, 40 sites, 2000-2010. MMWR Surveill Summ 2013; 62 (6): 1-19.
10. Pickett KE, Rathouz PJ, Kasza K, Wakschlag LS, Wright R. Self-reported smoking, cotinine levels, and patterns of smoking in pregnancy. Paediatr Perinat Epidemiol 2005; 19(5): 368-376.
11. Dukic VM, Niessner M, Pickett KE, Benowitz NL, Wakschlag LS. Calibrating selfreported measures of maternal smoking in pregnancy via bioassays using a Monte Carlo approach. Int J Environ Res Public Health 2009; 6(6): 1744-1759.
12. Howland RE, Mulready-Ward C, Madsen AM, Sackoff J, Nyland-Funke M, Bombard JM, et al. Reliability of reported maternal smoking: comparing the birth certificate to maternal worksheets and prenatal and hospital medical records, New York City and Vermont, 2009. Matern Child Health J 2015; 19(9): 1916-1924.
13. Dietz PM, Homa D, England LJ, Burley K, Tong VT, Dube SR, et al. Estimates of nondisclosure of cigarette smoking among pregnant and nonpregnant women of reproductive age in the United States. Am J Epidemiol 2011; 173(3): 355-359.
14. Tong VT, Althabe F, Aleman A, Johnson CC, Dietz PM, Berrueta M, et al. Accuracy of self-reported smoking cessation during pregnancy. Acta Obstet Gynecol Scand 2015; 94(1): 106-111.
15. Wickstrom R. Effects of nicotine during pregnancy: human and experimental evidence. Curr Neuropharmacol 2007; 5(3): 213-222.
16. Evlampidou I, Bagkeris M, Vardavas C, Koutra K, Patelarou E, Koutis A, et al. Prenatal second-hand smoke exposure measured with urine cotinine may reduce gross motor development at 18 months of age. J Pediatr 2015; 167(2): 246-252 e242.
17. Ashford KB, Hahn E, Hall L, Rayens MK, Noland M, Ferguson JE. The effects of prenatal secondhand smoke exposure on preterm birth and neonatal outcomes. J Obstet Gynecol Neonatal Nurs 2010; 39(5): 525-535.
18. Benowitz NL. Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiol Rev 1996; 18(2): 188-204.
19. Etzel RA. A review of the use of saliva cotinine as a marker of tobacco smoke exposure. Prev Med 1990; 19(2): 190-197.
20. Benowitz NL, Hukkanen J, Jacob P 3rd. Nicotine chemistry, metabolism, kinetics and biomarkers. Handb Exp Pharmacol 2009; (192): 29-60.
21. Bernert JT Jr., McGuffey JE, Morrison MA, Pirkle JL. Comparison of serum and salivary cotinine measurements by a sensitive high-performance liquid chromatography- Tandem mass spectrometry method as an indicator of exposure to tobacco smoke among smokers and nonsmokers. J Anal Toxicol 2000; 24(5): 333-339.
22. Tuomi T, Johnsson T, Reijula K. Analysis of nicotine, 3-hydroxycotinine, cotinine, and caffeine in urine of passive smokers by HPLC- Tandem mass spectrometry. Clin Chem 1999; 45(12): 2164-2172.
23. Shin HS, Kim JG, Shin YJ, Jee SH. Sensitive and simple method for the determination of nicotine and cotinine in human urine, plasma and saliva by gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2002; 769(1): 177-183.
24. Dempsey D, Jacob P 3rd, Benowitz NL. Accelerated metabolism of nicotine and cotinine in pregnant smokers. J Pharmacol Exp Ther 2002; 301(2): 594-598.
25. Massatti R, Falb M, Yors A, Potts L, Beeghly C, Starr S. Neonatal abstinence syndrome and drug use among pregnant women in Ohio 2004-2011. 2013, Ohio Department of Mental Health and Addiction Services.: Columbus, OH.
26. Wexelblatt SL, Ward LP, Torok K, Tisdale E, Meinzen-Derr JK, Greenberg JM. Universal maternal drug testing in a high-prevalence region of prescription opiate abuse. J Pediatr 2015; 166(3): 582-586.
27. Hall ES, Meinzen-Derr J, Wexelblatt SL. Cohort analysis of a pharmacokineticmodeled methadone weaning optimization for neonatal abstinence syndrome. J Pediatr 2015; 167(6): 1221-1225 e1221.
28. Haufroid V, Lison D. Urinary cotinine as a tobacco-smoke exposure index: a minireview. Int Arch Occup Environ Health 1998; 71(3): 162-168.
29. Balhara YP, Jain R. A receiver operated curve-based evaluation of change in sensitivity and specificity of cotinine urinalysis for detecting active tobacco use. J Cancer Res Ther 2013; 9(1): 84-89.
30. Ohio Department of Health. Mother's worksheet for child's birth. 2014 [cited February 18, 2016] Available from http://vitalsupport.odh.ohio.gov/gd/gd.aspx?. Page=3&TopicRelationID=306&Content=5994.
31. American Cancer Society. Guide to quitting smoking 2014 [cited May 18, 2016] Available from http://www.cancer.org/acs/groups/cid/documents/webcontent/.002971-pdf.pdf
32. Song YM, Sung J, Cho HJ. Reduction and cessation of cigarette smoking and risk of cancer: a cohort study of Korean men. J Clin Oncol 2008; 26(31): 5101-5106.
33. Cradle Cincinnati. Our families, our future. 2015 [cited April 8, 2016] Available from http://www.cradlecincinnati.org/wp-content/uploads/2015/03/Annual-Report-2015-Compressed.pdf
34. Farsalinos KE, Polosa R. Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review. Ther Adv Drug Saf 2014; 5(2): 67-86.
35. American College of Obstetricians and Gynecologists. Committee opinion no. 471: Smoking cessation during pregnancy. Obstet Gynecol 2010; 116(5): 1241-1244.
36. Centers for Disease Control and Prevention. Global Youth Tobacco Survey (GYTS) core questionnaire with optional questions. Version 1.0. 2012 [cited May 5, 2016] Available from http://nccd.cdc.gov/GTSSData/Ancillary/DownloadAttachment. aspx'ID=33.
37. SAMHSA. Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2008-2011. 2012 [cited May 18, 2016] Available from http://.archive.samhsa.gov/data/NSDUH/2011SummNatFindDetTables/NSDUHDetTabsPDFWHTML2011/.2k11DetailedTabs/Web/HTML/NSDUH-DetTabsSect6pe Tabs55to107-2011.htm#Tab6.71B.
38. Patrick SW, Davis MM, Lehmann CU, Cooper WO. Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012. J Perinatol 2015; 35(8): 650-655.